
open access
메뉴
E-ISSN : 2671-6771
Neuromuscular diseases (NMDs) comprise a heterogeneous spectrum of inherited and acquired disorders affecting anterior horn cells, peripheral nerves, neuromuscular junctions, or skeletal muscle, resulting in progressive weakness, fatigue, and functional decline. Historically, exercise was discouraged due to concerns of “overuse weakness”; however, a growing body of evidence now supports the safety and efficacy of supervised submaximal exercise as a therapeutic intervention for various NMD subtypes. Moderate-intensity aerobic and strength training improves mitochondrial biogenesis, oxidative efficiency, and preserves neuromuscular integrity through activation of the AMPK–SIRT1–PGC-1α and mTORC1–Akt signaling pathways, while promoting antioxidant and anti-inflammatory responses. Individualized exercise programs tailored to the functional status of patients and adapted to the specific metabolic and structural characteristics of certain neuromuscular diseases improve endurance, muscle strength, and quality of life without accelerating disease progression. In the era of disease-modifying therapies, the role of exercise as a complementary measure to enhance therapeutic efficacy is gaining increasing scientific and clinical importance. A multimodal, individualized approach integrating aerobic exercise, strength training, flexibility training, respiratory training, and computer-assisted interventions under clinical supervision represents the current standard of care.